Periodic Paralysis Association Unites Global Community Igniting Inaugural Awareness Day for Ultra Rare Neuromuscular Condition.
The Periodic Paralysis Association is excited to announce that March 23rd, 2025 is the inaugural World Periodic Paralysis Day ...
Xeris Biopharma: Low Risk, Low Excitement Solid Revenue Generator
Explore Xeris Biopharma's revenue growth, promising pipeline, & thriving products. Learn about their strong outlook & ...
Stocktwits on MSN14d
Xeris Biopharma Stock Soars To Nearly 4-Year High On Strong 2025 Outlook, Retail Bulls Charge In
Shares of Xeris Biopharma Inc. surged more than 9.5% on Thursday, reaching their highest level since June 2021, driven by a ...
Business Wire21d
Xeris Biopharma to Report Fourth Quarter and Full-Year 2024 Financial Results on March 6, 2025
and Keveyis®, a proven therapy for primary periodic paralysis. Xeris also has a pipeline of development programs led by XP-8121, a Phase 3-ready, once-weekly subcutaneous injection for ...
ADVFN1mon
Xeris to Participate in Upcoming Investor Conferences
and Keveyis®, a proven therapy for primary periodic paralysis. Xeris also has a pipeline of development programs led by XP-8121, a Phase 3-ready, once-weekly subcutaneous injection for ...